229 related articles for article (PubMed ID: 34933878)
1. Adherence to guidance for prioritizing higher risk groups for breast cancer screening during the COVID-19 pandemic in the Ontario Breast Screening Program: a descriptive study.
Chiarelli AM; Walker MJ; Espino-Hernandez G; Gray N; Salleh A; Adhihetty C; Gao J; Fienberg S; Rey MA; Rabeneck L
CMAJ Open; 2021; 9(4):E1205-E1212. PubMed ID: 34933878
[TBL] [Abstract][Full Text] [Related]
2. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
[TBL] [Abstract][Full Text] [Related]
3. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
[TBL] [Abstract][Full Text] [Related]
4. Annual vs Biennial Screening: Diagnostic Accuracy Among Concurrent Cohorts Within the Ontario Breast Screening Program.
Chiarelli AM; Blackmore KM; Mirea L; Done SJ; Majpruz V; Weerasinghe A; Rabeneck L; Muradali D
J Natl Cancer Inst; 2020 Apr; 112(4):400-409. PubMed ID: 31233138
[TBL] [Abstract][Full Text] [Related]
5. Delivery of Cancer Care in Ontario, Canada, During the First Year of the COVID-19 Pandemic.
Walker MJ; Wang J; Mazuryk J; Skinner SM; Meggetto O; Ashu E; Habbous S; Nazeri Rad N; Espino-Hernández G; Wood R; Chaudhry M; Vahid S; Gao J; Gallo-Hershberg D; Gutierrez E; Zanchetta C; Langer D; Zwicker V; Rey M; Tammemägi MC; Tinmouth J; Kupets R; Chiarelli AM; Singh S; Warde P; Forbes L; Dobranowski J; Irish J; Rabeneck L;
JAMA Netw Open; 2022 Apr; 5(4):e228855. PubMed ID: 35467731
[TBL] [Abstract][Full Text] [Related]
6. Annual Mammographic Screening Reduces the Risk of Interval or Higher Stage Invasive Breast Cancers Among Postmenopausal Women in the Ontario Breast Screening Program.
Blackmore KM; Chiarelli AM; Mirea L; Mittmann N; Muradali D; Rabeneck L; Done SJ
Can Assoc Radiol J; 2022 Aug; 73(3):524-534. PubMed ID: 35068172
[No Abstract] [Full Text] [Related]
7. Cancer Screening Disparities Before and After the COVID-19 Pandemic.
Lofters AK; Wu F; Frymire E; Kiran T; Vahabi M; Green ME; Glazier RH
JAMA Netw Open; 2023 Nov; 6(11):e2343796. PubMed ID: 37983033
[TBL] [Abstract][Full Text] [Related]
8. Impact of the COVID-19 Pandemic on Breast Imaging: An Analysis of the National Mammography Database.
Grimm LJ; Lee C; Rosenberg RD; Burleson J; Simanowith M; Fruscello T; Pelzl CE; Friedewald SM; Moy L; Zuley ML
J Am Coll Radiol; 2022 Aug; 19(8):919-934. PubMed ID: 35690079
[TBL] [Abstract][Full Text] [Related]
9. Using Real-World Data to Determine Health System Costs of Ontario Women Screened for Breast Cancer.
Mittmann N; Seung SJ; Diong C; Gatley JM; Wolfson M; Guertin MH; Pashayan N; Simard J; Chiarelli AM
Curr Oncol; 2022 Oct; 29(11):8330-8339. PubMed ID: 36354717
[TBL] [Abstract][Full Text] [Related]
10. Results from the Ontario breast screening program, 1990-1995.
Libstug AR; Moravan V; Aitken SE
J Med Screen; 1998; 5(2):73-80. PubMed ID: 9718525
[TBL] [Abstract][Full Text] [Related]
11. The cumulative risk of false-positive results in the Norwegian Breast Cancer Screening Program: updated results.
Roman M; Hubbard RA; Sebuodegard S; Miglioretti DL; Castells X; Hofvind S
Cancer; 2013 Nov; 119(22):3952-8. PubMed ID: 23963877
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer detection method, diagnostic interval and use of specialized diagnostic assessment units across Ontario, Canada.
Jiang L; Gilbert J; Langley H; Moineddin R; Groome PA
Health Promot Chronic Dis Prev Can; 2018 Oct; 38(10):358-367. PubMed ID: 30303656
[TBL] [Abstract][Full Text] [Related]
13. Performance measures from 10 years of breast screening in the Ontario Breast Screening Program, 1990/91 to 2000.
Chiarelli AM; Halapy E; Nadalin V; Shumak R; O'Malley F; Mai V
Eur J Cancer Prev; 2006 Feb; 15(1):34-42. PubMed ID: 16374227
[TBL] [Abstract][Full Text] [Related]
14. Ultrasound as an Adjunct to Mammography for Breast Cancer Screening: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(15):1-71. PubMed ID: 27468326
[TBL] [Abstract][Full Text] [Related]
15. The ophthalmic surgical backlog associated with the COVID-19 pandemic: a population-based and microsimulation modelling study.
Felfeli T; Ximenes R; Naimark DMJ; Hooper PL; Campbell RJ; El-Defrawy SR; Sander B
CMAJ Open; 2021; 9(4):E1063-E1072. PubMed ID: 34815262
[TBL] [Abstract][Full Text] [Related]
16. Changes in mammographic density over time and the risk of breast cancer: An observational cohort study.
Román M; Sala M; Baré M; Posso M; Vidal C; Louro J; Sánchez M; Peñalva L; Castells X;
Breast; 2019 Aug; 46():108-115. PubMed ID: 31132476
[TBL] [Abstract][Full Text] [Related]
17. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
18. The National Breast and Cervical Cancer Early Detection Program: report on the first 4 years of mammography provided to medically underserved women.
May DS; Lee NC; Nadel MR; Henson RM; Miller DS
AJR Am J Roentgenol; 1998 Jan; 170(1):97-104. PubMed ID: 9423608
[TBL] [Abstract][Full Text] [Related]
19. Screening behaviours, demographics, and stage at diagnosis in the publicly funded Ontario Breast Screening Program.
Gold N; Christensen RAG; Arneja J; Aminoleslami A; Anderson GM; Brooks JD
Breast Cancer Res Treat; 2023 Apr; 198(3):523-533. PubMed ID: 36800117
[TBL] [Abstract][Full Text] [Related]
20. Mammographic screening for breast cancer: 2010.
Margolies L
Mt Sinai J Med; 2010; 77(4):398-404. PubMed ID: 20687187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
